Sort
34,240 grants matching “atherosclerosis”
Unraveling the role of endothelium in chemotherapy-induced cardiotoxicity
$394,436Nazish Sayed · Stanford University · R01 · FY2025 · HL
Mouse Model and Protein Expression Core
$394,353Loren Gi Fong · University Of California Los Angeles · P01 · FY2014 · HL
Pathways that regulate monocyte/dendritic cell migration
$394,330Gwendalyn J Randolph · Icahn School Of Medicine At Mount Sinai · R01 · FY2009 · AI
Pathways that regulate monocyte/dendritic cell migration
$394,330Gwendalyn J Randolph · Icahn School Of Medicine At Mount Sinai · R01 · FY2008 · AI
Arterial stiffening and SMC mechanobiology in Hutchinson-Guilford Progeria Syndrome
$394,277Richard Assoian · University Of Pennsylvania · R01 · FY2021 · AG
PROJECT 2 - METABOLIC CONTROL OF REPRODUCTION
$394,277Jerrold M Olefsky · University Of California, San Diego · U54 · FY2009 · HD
REGULATION OF VESSEL WALL APOPTOSIS
$394,262Kenneth Walsh · Boston University Medical Campus · R37 · FY2006 · AG
Inflammation and Infection in Atherosclerosis
$394,262Salomon Amar · Boston University Medical Campus · R01 · FY2006 · HL
Hypochlorite-Mediated Impairment of Endothelial Function
$394,262John F. Keaney · Boston University Medical Campus · R01 · FY2006 · HL
TIMP Engineering and Application to Arthritis
$394,243Florida Atlantic University · R01 · FY2003 · AR
VASCULAR BIOLOGY, THROMBOSIS, AND HEMOSTASIS
$394,206Scripps Research Institute · T32 · FY2005 · HL
Stress and Platelet NPY in Vascular Remodeling
$394,185Zofia Zukowska · University Of Minnesota · R37 · FY2011 · HL
The Role of CD13 and its activators in vascular inflammation
$394,160Linda H Shapiro · University Of Connecticut Sch Of Med/Dnt · P01 · FY2009 · HL
Family Study of Atherosclerosis and Vascular Cognitive Dysfunction
$394,140Tatjana Rundek · University Of Miami School Of Medicine · R01 · FY2019 · NS
Molecular Mechanisms for Dysfunctional High Density Lipoprotein (HDL)
$394,126Jay W Heinecke · University Of Washington · R01 · FY2007 · HL
Perfluoroalkyl chemicals and the risk of developing clinical and subclinical CVD
$394,065Anoop Shankar · West Virginia University · R01 · FY2012 · ES
Role of LITAF in Inflammatory Processes
$394,063Salomon Amar · Boston University Medical Campus · R01 · FY2007 · DE
Mechanisms of NIrp3 inflammasome activation by mitochondrial dysfunction
$394,039Suzanne L. Cassel · Cedars-Sinai Medical Center · R01 · FY2016 · AI
Risk Factors for CVD in Women
$394,009Brigham And Women'S Hospital · R01 · FY2002 · HL
HDL, platelet progenitors, atherosclerosis and thrombosis
$394,000Nan Wang · Columbia University Health Sciences · R01 · FY2015 · HL
Transcriptional Regulation of PDGF by Endothelium
$394,000Mark D. Fleming · Boston Children'S Hospital · R01 · FY2007 · HL
Role of apolipoprotein E4 in the progression and regression of atherosclerosis
$394,000Robert Raffai · Northern California Institute/Res/Edu · R01 · FY2007 · HL
Role of apolipoprotein E4 in the progression and regression of atherosclerosis
$394,000Robert Raffai · Northern California Institute/Res/Edu · R01 · FY2009 · HL
Role of apolipoprotein E4 in the progression and regression of atherosclerosis
$394,000Robert Raffai · Northern California Institute/Res/Edu · R01 · FY2011 · HL
Role of apolipoprotein E4 in the progression and regression of atherosclerosis
$394,000Robert Raffai · Northern California Institute/Res/Edu · R01 · FY2010 · HL